nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—PGR—multiple sclerosis	0.234	1	CbGaD
Spironolactone—NR3C2—Betamethasone—multiple sclerosis	0.0486	0.137	CbGbCtD
Spironolactone—NR3C2—Prednisolone—multiple sclerosis	0.0479	0.135	CbGbCtD
Spironolactone—PGR—Betamethasone—multiple sclerosis	0.0314	0.0884	CbGbCtD
Spironolactone—NR3C2—Dexamethasone—multiple sclerosis	0.0282	0.0797	CbGbCtD
Spironolactone—NR3C1—Methylprednisolone—multiple sclerosis	0.0246	0.0695	CbGbCtD
Spironolactone—NR3C1—Triamcinolone—multiple sclerosis	0.0187	0.0527	CbGbCtD
Spironolactone—PGR—Dexamethasone—multiple sclerosis	0.0182	0.0514	CbGbCtD
Spironolactone—NR3C1—Betamethasone—multiple sclerosis	0.016	0.0452	CbGbCtD
Spironolactone—NR3C1—Prednisolone—multiple sclerosis	0.0158	0.0446	CbGbCtD
Spironolactone—NR3C1—Prednisone—multiple sclerosis	0.0149	0.0421	CbGbCtD
Spironolactone—Potassium Canrenoate—Prednisone—multiple sclerosis	0.0142	0.0422	CrCrCtD
Spironolactone—Potassium Canrenoate—Prednisolone—multiple sclerosis	0.0138	0.0412	CrCrCtD
Spironolactone—SLCO1A2—Prednisolone—multiple sclerosis	0.0136	0.0384	CbGbCtD
Spironolactone—SLCO1A2—Prednisone—multiple sclerosis	0.0129	0.0363	CbGbCtD
Spironolactone—Medroxyprogesterone Acetate—Methylprednisolone—multiple sclerosis	0.0126	0.0376	CrCrCtD
Spironolactone—Hydrocortamate—Methylprednisolone—multiple sclerosis	0.0114	0.034	CrCrCtD
Spironolactone—Cortisone acetate—Methylprednisolone—multiple sclerosis	0.011	0.0329	CrCrCtD
Spironolactone—Testolactone—Methylprednisolone—multiple sclerosis	0.0107	0.032	CrCrCtD
Spironolactone—Testolactone—Betamethasone—multiple sclerosis	0.0105	0.0315	CrCrCtD
Spironolactone—Testolactone—Dexamethasone—multiple sclerosis	0.0105	0.0315	CrCrCtD
Spironolactone—Hydrocortamate—Prednisone—multiple sclerosis	0.0104	0.031	CrCrCtD
Spironolactone—Testolactone—Triamcinolone—multiple sclerosis	0.0103	0.0307	CrCrCtD
Spironolactone—Hydrocortamate—Prednisolone—multiple sclerosis	0.0101	0.0303	CrCrCtD
Spironolactone—Cortisone acetate—Prednisone—multiple sclerosis	0.0101	0.0301	CrCrCtD
Spironolactone—Cortisone acetate—Prednisolone—multiple sclerosis	0.00983	0.0293	CrCrCtD
Spironolactone—Testolactone—Prednisone—multiple sclerosis	0.00977	0.0292	CrCrCtD
Spironolactone—Fluoxymesterone—Betamethasone—multiple sclerosis	0.00969	0.0289	CrCrCtD
Spironolactone—Fluoxymesterone—Dexamethasone—multiple sclerosis	0.00969	0.0289	CrCrCtD
Spironolactone—Fludrocortisone—Methylprednisolone—multiple sclerosis	0.00959	0.0286	CrCrCtD
Spironolactone—Testolactone—Prednisolone—multiple sclerosis	0.00954	0.0285	CrCrCtD
Spironolactone—Fluoxymesterone—Triamcinolone—multiple sclerosis	0.00947	0.0282	CrCrCtD
Spironolactone—Fludrocortisone—Betamethasone—multiple sclerosis	0.00944	0.0282	CrCrCtD
Spironolactone—Fludrocortisone—Dexamethasone—multiple sclerosis	0.00944	0.0282	CrCrCtD
Spironolactone—NR3C1—Dexamethasone—multiple sclerosis	0.00932	0.0263	CbGbCtD
Spironolactone—Fludrocortisone—Triamcinolone—multiple sclerosis	0.00922	0.0275	CrCrCtD
Spironolactone—Fluoxymesterone—Prednisolone—multiple sclerosis	0.00877	0.0262	CrCrCtD
Spironolactone—Fludrocortisone—Prednisone—multiple sclerosis	0.00875	0.0261	CrCrCtD
Spironolactone—Fludrocortisone—Prednisolone—multiple sclerosis	0.00854	0.0255	CrCrCtD
Spironolactone—Progesterone—Prednisolone—multiple sclerosis	0.00854	0.0255	CrCrCtD
Spironolactone—Methyltestosterone—Prednisone—multiple sclerosis	0.00853	0.0255	CrCrCtD
Spironolactone—Methyltestosterone—Prednisolone—multiple sclerosis	0.00833	0.0249	CrCrCtD
Spironolactone—SLCO1A2—Dexamethasone—multiple sclerosis	0.00803	0.0226	CbGbCtD
Spironolactone—Hydrocortisone—Methylprednisolone—multiple sclerosis	0.00782	0.0233	CrCrCtD
Spironolactone—Hydrocortisone—Betamethasone—multiple sclerosis	0.0077	0.023	CrCrCtD
Spironolactone—Hydrocortisone—Dexamethasone—multiple sclerosis	0.0077	0.023	CrCrCtD
Spironolactone—Hydrocortisone—Triamcinolone—multiple sclerosis	0.00752	0.0224	CrCrCtD
Spironolactone—Testosterone—Prednisolone—multiple sclerosis	0.00741	0.0221	CrCrCtD
Spironolactone—Hydrocortisone—Prednisone—multiple sclerosis	0.00714	0.0213	CrCrCtD
Spironolactone—Hydrocortisone—Prednisolone—multiple sclerosis	0.00697	0.0208	CrCrCtD
Spironolactone—ABCC2—Dexamethasone—multiple sclerosis	0.00666	0.0188	CbGbCtD
Spironolactone—SLCO1A2—Methotrexate—multiple sclerosis	0.00645	0.0182	CbGbCtD
Spironolactone—ABCB1—Methylprednisolone—multiple sclerosis	0.00574	0.0162	CbGbCtD
Spironolactone—ABCC2—Methotrexate—multiple sclerosis	0.00535	0.0151	CbGbCtD
Spironolactone—ABCB1—Mitoxantrone—multiple sclerosis	0.00418	0.0118	CbGbCtD
Spironolactone—ABCB1—Betamethasone—multiple sclerosis	0.00373	0.0105	CbGbCtD
Spironolactone—ABCB1—Prednisolone—multiple sclerosis	0.00368	0.0104	CbGbCtD
Spironolactone—ABCB1—Prednisone—multiple sclerosis	0.00348	0.0098	CbGbCtD
Spironolactone—CYP2C8—Dexamethasone—multiple sclerosis	0.00321	0.00904	CbGbCtD
Spironolactone—ABCB1—Dexamethasone—multiple sclerosis	0.00217	0.00612	CbGbCtD
Spironolactone—Gastric haemorrhage—Methylprednisolone—multiple sclerosis	0.00204	0.0539	CcSEcCtD
Spironolactone—ABCB1—Methotrexate—multiple sclerosis	0.00174	0.00492	CbGbCtD
Spironolactone—Rash erythematous—Cladribine—multiple sclerosis	0.000676	0.0178	CcSEcCtD
Spironolactone—Hypertrichosis—Triamcinolone—multiple sclerosis	0.000676	0.0178	CcSEcCtD
Spironolactone—Hypertrichosis—Methylprednisolone—multiple sclerosis	0.000674	0.0178	CcSEcCtD
Spironolactone—Hypertrichosis—Dexamethasone—multiple sclerosis	0.000613	0.0162	CcSEcCtD
Spironolactone—Hypertrichosis—Betamethasone—multiple sclerosis	0.000613	0.0162	CcSEcCtD
Spironolactone—Dydrogesterone—PGR—multiple sclerosis	0.000591	0.314	CrCbGaD
Spironolactone—Hypertrichosis—Prednisone—multiple sclerosis	0.000534	0.0141	CcSEcCtD
Spironolactone—Menstruation irregular—Prednisolone—multiple sclerosis	0.000504	0.0133	CcSEcCtD
Spironolactone—Menstruation irregular—Triamcinolone—multiple sclerosis	0.000464	0.0122	CcSEcCtD
Spironolactone—Menstruation irregular—Methylprednisolone—multiple sclerosis	0.000463	0.0122	CcSEcCtD
Spironolactone—Vasculitis—Azathioprine—multiple sclerosis	0.000432	0.0114	CcSEcCtD
Spironolactone—Menstruation irregular—Dexamethasone—multiple sclerosis	0.000421	0.0111	CcSEcCtD
Spironolactone—Menstruation irregular—Betamethasone—multiple sclerosis	0.000421	0.0111	CcSEcCtD
Spironolactone—Renal failure acute—Cladribine—multiple sclerosis	0.000407	0.0107	CcSEcCtD
Spironolactone—Alopecia—Fingolimod—multiple sclerosis	0.000405	0.0107	CcSEcCtD
Spironolactone—Amenorrhoea—Mitoxantrone—multiple sclerosis	0.000387	0.0102	CcSEcCtD
Spironolactone—Lethargy—Cladribine—multiple sclerosis	0.000384	0.0101	CcSEcCtD
Spironolactone—Menstruation irregular—Prednisone—multiple sclerosis	0.000367	0.00967	CcSEcCtD
Spironolactone—Ulcer—Mitoxantrone—multiple sclerosis	0.00036	0.00949	CcSEcCtD
Spironolactone—Leukopenia—Fingolimod—multiple sclerosis	0.000358	0.00943	CcSEcCtD
Spironolactone—Megestrol acetate—PGR—multiple sclerosis	0.000356	0.189	CrCbGaD
Spironolactone—Ataxia—Cladribine—multiple sclerosis	0.000354	0.00933	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Cladribine—multiple sclerosis	0.000339	0.00893	CcSEcCtD
Spironolactone—Hyperkalaemia—Mitoxantrone—multiple sclerosis	0.000334	0.00882	CcSEcCtD
Spironolactone—Eosinophilia—Cladribine—multiple sclerosis	0.000322	0.00849	CcSEcCtD
Spironolactone—Drospirenone—PGR—multiple sclerosis	0.000311	0.165	CrCbGaD
Spironolactone—Rash erythematous—Dexamethasone—multiple sclerosis	0.000304	0.00803	CcSEcCtD
Spironolactone—Rash erythematous—Betamethasone—multiple sclerosis	0.000304	0.00803	CcSEcCtD
Spironolactone—Amenorrhoea—Methylprednisolone—multiple sclerosis	0.000292	0.00769	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Cladribine—multiple sclerosis	0.000287	0.00758	CcSEcCtD
Spironolactone—Vasculitis—Prednisolone—multiple sclerosis	0.000286	0.00755	CcSEcCtD
Spironolactone—Renal failure—Cladribine—multiple sclerosis	0.000285	0.00751	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.000281	0.00742	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Azathioprine—multiple sclerosis	0.000275	0.00726	CcSEcCtD
Spironolactone—Ulcer—Triamcinolone—multiple sclerosis	0.000272	0.00716	CcSEcCtD
Spironolactone—NR3C1—nerve—multiple sclerosis	0.000268	0.0611	CbGeAlD
Spironolactone—Renal failure acute—Mitoxantrone—multiple sclerosis	0.000268	0.00706	CcSEcCtD
Spironolactone—Amenorrhoea—Dexamethasone—multiple sclerosis	0.000265	0.007	CcSEcCtD
Spironolactone—Amenorrhoea—Betamethasone—multiple sclerosis	0.000265	0.007	CcSEcCtD
Spironolactone—Vasculitis—Triamcinolone—multiple sclerosis	0.000263	0.00694	CcSEcCtD
Spironolactone—Vasculitis—Methylprednisolone—multiple sclerosis	0.000263	0.00693	CcSEcCtD
Spironolactone—Ulcer—Dexamethasone—multiple sclerosis	0.000246	0.0065	CcSEcCtD
Spironolactone—Ulcer—Betamethasone—multiple sclerosis	0.000246	0.0065	CcSEcCtD
Spironolactone—Erythema multiforme—Cladribine—multiple sclerosis	0.000246	0.00649	CcSEcCtD
Spironolactone—Vasculitis—Dexamethasone—multiple sclerosis	0.000239	0.0063	CcSEcCtD
Spironolactone—Vasculitis—Betamethasone—multiple sclerosis	0.000239	0.0063	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Azathioprine—multiple sclerosis	0.000234	0.00616	CcSEcCtD
Spironolactone—Amenorrhoea—Prednisone—multiple sclerosis	0.000231	0.00609	CcSEcCtD
Spironolactone—Pruritus—Fingolimod—multiple sclerosis	0.000231	0.00608	CcSEcCtD
Spironolactone—Alopecia—Cladribine—multiple sclerosis	0.00023	0.00606	CcSEcCtD
Spironolactone—Diarrhoea—Fingolimod—multiple sclerosis	0.000223	0.00588	CcSEcCtD
Spironolactone—SHBG—brainstem—multiple sclerosis	0.000222	0.0505	CbGeAlD
Spironolactone—Agranulocytosis—Azathioprine—multiple sclerosis	0.00022	0.0058	CcSEcCtD
Spironolactone—Dizziness—Fingolimod—multiple sclerosis	0.000216	0.00569	CcSEcCtD
Spironolactone—NR3C2—brainstem—multiple sclerosis	0.000215	0.0489	CbGeAlD
Spironolactone—Ulcer—Prednisone—multiple sclerosis	0.000215	0.00566	CcSEcCtD
Spironolactone—Drospirenone—BCHE—multiple sclerosis	0.000213	0.113	CrCbGaD
Spironolactone—Ill-defined disorder—Cladribine—multiple sclerosis	0.00021	0.00554	CcSEcCtD
Spironolactone—Vasculitis—Prednisone—multiple sclerosis	0.000208	0.00549	CcSEcCtD
Spironolactone—Medroxyprogesterone Acetate—PGR—multiple sclerosis	0.000207	0.11	CrCbGaD
Spironolactone—NR3C2—retina—multiple sclerosis	0.000207	0.0472	CbGeAlD
Spironolactone—Headache—Fingolimod—multiple sclerosis	0.000204	0.00539	CcSEcCtD
Spironolactone—Malaise—Cladribine—multiple sclerosis	0.000204	0.00539	CcSEcCtD
Spironolactone—Erythema multiforme—Azathioprine—multiple sclerosis	0.0002	0.00527	CcSEcCtD
Spironolactone—Erectile dysfunction—Mitoxantrone—multiple sclerosis	0.000197	0.00519	CcSEcCtD
Spironolactone—Discomfort—Cladribine—multiple sclerosis	0.00019	0.00502	CcSEcCtD
Spironolactone—Drowsiness—Mitoxantrone—multiple sclerosis	0.00019	0.00502	CcSEcCtD
Spironolactone—Renal failure—Mitoxantrone—multiple sclerosis	0.000187	0.00494	CcSEcCtD
Spironolactone—Alopecia—Azathioprine—multiple sclerosis	0.000187	0.00493	CcSEcCtD
Spironolactone—Confusional state—Cladribine—multiple sclerosis	0.000186	0.00492	CcSEcCtD
Spironolactone—Thrombocytopenia—Cladribine—multiple sclerosis	0.000181	0.00477	CcSEcCtD
Spironolactone—Ulcer—Methotrexate—multiple sclerosis	0.000179	0.00473	CcSEcCtD
Spironolactone—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.000178	0.00469	CcSEcCtD
Spironolactone—Vasculitis—Methotrexate—multiple sclerosis	0.000174	0.00458	CcSEcCtD
Spironolactone—Lethargy—Betamethasone—multiple sclerosis	0.000173	0.00455	CcSEcCtD
Spironolactone—Lethargy—Dexamethasone—multiple sclerosis	0.000173	0.00455	CcSEcCtD
Spironolactone—Ill-defined disorder—Azathioprine—multiple sclerosis	0.000171	0.00451	CcSEcCtD
Spironolactone—Malaise—Azathioprine—multiple sclerosis	0.000166	0.00438	CcSEcCtD
Spironolactone—Leukopenia—Azathioprine—multiple sclerosis	0.000165	0.00435	CcSEcCtD
Spironolactone—Somnolence—Cladribine—multiple sclerosis	0.000164	0.00433	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.00016	0.00421	CcSEcCtD
Spironolactone—Discomfort—Azathioprine—multiple sclerosis	0.000155	0.00409	CcSEcCtD
Spironolactone—Feeling abnormal—Cladribine—multiple sclerosis	0.000152	0.00402	CcSEcCtD
Spironolactone—Gynaecomastia—Methotrexate—multiple sclerosis	0.000152	0.004	CcSEcCtD
Spironolactone—Alopecia—Mitoxantrone—multiple sclerosis	0.000151	0.00399	CcSEcCtD
Spironolactone—Lethargy—Prednisone—multiple sclerosis	0.00015	0.00397	CcSEcCtD
Spironolactone—NR3C2—medulla oblongata—multiple sclerosis	0.00015	0.0341	CbGeAlD
Spironolactone—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000147	0.00388	CcSEcCtD
Spironolactone—Urticaria—Cladribine—multiple sclerosis	0.000147	0.00387	CcSEcCtD
Spironolactone—Body temperature increased—Cladribine—multiple sclerosis	0.000146	0.00385	CcSEcCtD
Spironolactone—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.000138	0.00364	CcSEcCtD
Spironolactone—NR3C2—midbrain—multiple sclerosis	0.000137	0.0312	CbGeAlD
Spironolactone—Hypersensitivity—Cladribine—multiple sclerosis	0.000136	0.00359	CcSEcCtD
Spironolactone—Malaise—Mitoxantrone—multiple sclerosis	0.000134	0.00354	CcSEcCtD
Spironolactone—NR3C2—spinal cord—multiple sclerosis	0.000134	0.0304	CbGeAlD
Spironolactone—Renal failure acute—Methotrexate—multiple sclerosis	0.000133	0.00352	CcSEcCtD
Spironolactone—Leukopenia—Mitoxantrone—multiple sclerosis	0.000133	0.00351	CcSEcCtD
Spironolactone—Pruritus—Cladribine—multiple sclerosis	0.000131	0.00345	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.00013	0.00342	CcSEcCtD
Spironolactone—SLCO1A2—medulla oblongata—multiple sclerosis	0.000128	0.0292	CbGeAlD
Spironolactone—Diarrhoea—Cladribine—multiple sclerosis	0.000126	0.00334	CcSEcCtD
Spironolactone—Lethargy—Methotrexate—multiple sclerosis	0.000126	0.00331	CcSEcCtD
Spironolactone—Discomfort—Mitoxantrone—multiple sclerosis	0.000125	0.0033	CcSEcCtD
Spironolactone—Feeling abnormal—Azathioprine—multiple sclerosis	0.000124	0.00327	CcSEcCtD
Spironolactone—Confusional state—Mitoxantrone—multiple sclerosis	0.000122	0.00323	CcSEcCtD
Spironolactone—Dizziness—Cladribine—multiple sclerosis	0.000122	0.00322	CcSEcCtD
Spironolactone—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000121	0.0032	CcSEcCtD
Spironolactone—Progesterone—PGR—multiple sclerosis	0.00012	0.0635	CrCbGaD
Spironolactone—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000119	0.00314	CcSEcCtD
Spironolactone—Body temperature increased—Azathioprine—multiple sclerosis	0.000119	0.00313	CcSEcCtD
Spironolactone—Vomiting—Cladribine—multiple sclerosis	0.000117	0.0031	CcSEcCtD
Spironolactone—SLCO1A2—midbrain—multiple sclerosis	0.000117	0.0267	CbGeAlD
Spironolactone—Erectile dysfunction—Prednisone—multiple sclerosis	0.000117	0.00309	CcSEcCtD
Spironolactone—Rash—Cladribine—multiple sclerosis	0.000117	0.00307	CcSEcCtD
Spironolactone—Dermatitis—Cladribine—multiple sclerosis	0.000116	0.00307	CcSEcCtD
Spironolactone—Ataxia—Methotrexate—multiple sclerosis	0.000116	0.00305	CcSEcCtD
Spironolactone—Headache—Cladribine—multiple sclerosis	0.000116	0.00305	CcSEcCtD
Spironolactone—NR3C1—brainstem—multiple sclerosis	0.000115	0.0262	CbGeAlD
Spironolactone—SLCO1A2—spinal cord—multiple sclerosis	0.000114	0.0261	CbGeAlD
Spironolactone—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000113	0.00299	CcSEcCtD
Spironolactone—NR3C2—nervous system—multiple sclerosis	0.000113	0.0256	CbGeAlD
Spironolactone—SHBG—central nervous system—multiple sclerosis	0.000112	0.0255	CbGeAlD
Spironolactone—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.000111	0.00292	CcSEcCtD
Spironolactone—Hypersensitivity—Azathioprine—multiple sclerosis	0.000111	0.00292	CcSEcCtD
Spironolactone—Malaise—Prednisolone—multiple sclerosis	0.00011	0.0029	CcSEcCtD
Spironolactone—Nausea—Cladribine—multiple sclerosis	0.00011	0.0029	CcSEcCtD
Spironolactone—SHBG—cerebellum—multiple sclerosis	0.000109	0.0249	CbGeAlD
Spironolactone—NR3C2—central nervous system—multiple sclerosis	0.000108	0.0247	CbGeAlD
Spironolactone—Somnolence—Mitoxantrone—multiple sclerosis	0.000108	0.00285	CcSEcCtD
Spironolactone—NR3C2—cerebellum—multiple sclerosis	0.000106	0.0241	CbGeAlD
Spironolactone—Eosinophilia—Methotrexate—multiple sclerosis	0.000105	0.00278	CcSEcCtD
Spironolactone—PGR—nervous system—multiple sclerosis	0.000105	0.0238	CbGeAlD
Spironolactone—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000104	0.00275	CcSEcCtD
Spironolactone—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000104	0.00274	CcSEcCtD
Spironolactone—Alopecia—Betamethasone—multiple sclerosis	0.000103	0.00273	CcSEcCtD
Spironolactone—Alopecia—Dexamethasone—multiple sclerosis	0.000103	0.00273	CcSEcCtD
Spironolactone—Diarrhoea—Azathioprine—multiple sclerosis	0.000103	0.00271	CcSEcCtD
Spironolactone—Discomfort—Prednisolone—multiple sclerosis	0.000103	0.00271	CcSEcCtD
Spironolactone—Malaise—Triamcinolone—multiple sclerosis	0.000101	0.00267	CcSEcCtD
Spironolactone—Malaise—Methylprednisolone—multiple sclerosis	0.000101	0.00267	CcSEcCtD
Spironolactone—PGR—central nervous system—multiple sclerosis	0.000101	0.0229	CbGeAlD
Spironolactone—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.0001	0.00264	CcSEcCtD
Spironolactone—Anaphylactic shock—Prednisolone—multiple sclerosis	9.97e-05	0.00263	CcSEcCtD
Spironolactone—Dizziness—Azathioprine—multiple sclerosis	9.94e-05	0.00262	CcSEcCtD
Spironolactone—AR—spinal cord—multiple sclerosis	9.89e-05	0.0225	CbGeAlD
Spironolactone—PGR—cerebellum—multiple sclerosis	9.84e-05	0.0224	CbGeAlD
Spironolactone—Erectile dysfunction—Methotrexate—multiple sclerosis	9.8e-05	0.00259	CcSEcCtD
Spironolactone—Urticaria—Mitoxantrone—multiple sclerosis	9.65e-05	0.00255	CcSEcCtD
Spironolactone—SLCO1A2—nervous system—multiple sclerosis	9.65e-05	0.022	CbGeAlD
Spironolactone—Body temperature increased—Mitoxantrone—multiple sclerosis	9.6e-05	0.00253	CcSEcCtD
Spironolactone—Vomiting—Azathioprine—multiple sclerosis	9.55e-05	0.00252	CcSEcCtD
Spironolactone—Drowsiness—Methotrexate—multiple sclerosis	9.49e-05	0.0025	CcSEcCtD
Spironolactone—Rash—Azathioprine—multiple sclerosis	9.47e-05	0.0025	CcSEcCtD
Spironolactone—Dermatitis—Azathioprine—multiple sclerosis	9.47e-05	0.0025	CcSEcCtD
Spironolactone—Ill-defined disorder—Dexamethasone—multiple sclerosis	9.45e-05	0.00249	CcSEcCtD
Spironolactone—Ill-defined disorder—Betamethasone—multiple sclerosis	9.45e-05	0.00249	CcSEcCtD
Spironolactone—Discomfort—Triamcinolone—multiple sclerosis	9.44e-05	0.00249	CcSEcCtD
Spironolactone—Discomfort—Methylprednisolone—multiple sclerosis	9.42e-05	0.00249	CcSEcCtD
Spironolactone—Headache—Azathioprine—multiple sclerosis	9.41e-05	0.00248	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	9.41e-05	0.00248	CcSEcCtD
Spironolactone—Renal failure—Methotrexate—multiple sclerosis	9.33e-05	0.00246	CcSEcCtD
Spironolactone—SLCO1A2—central nervous system—multiple sclerosis	9.29e-05	0.0211	CbGeAlD
Spironolactone—Confusional state—Methylprednisolone—multiple sclerosis	9.22e-05	0.00243	CcSEcCtD
Spironolactone—Malaise—Dexamethasone—multiple sclerosis	9.19e-05	0.00242	CcSEcCtD
Spironolactone—Malaise—Betamethasone—multiple sclerosis	9.19e-05	0.00242	CcSEcCtD
Spironolactone—Anaphylactic shock—Triamcinolone—multiple sclerosis	9.16e-05	0.00242	CcSEcCtD
Spironolactone—Anaphylactic shock—Methylprednisolone—multiple sclerosis	9.14e-05	0.00241	CcSEcCtD
Spironolactone—SLCO1A2—cerebellum—multiple sclerosis	9.08e-05	0.0207	CbGeAlD
Spironolactone—Alopecia—Prednisone—multiple sclerosis	9.01e-05	0.00238	CcSEcCtD
Spironolactone—Hypersensitivity—Mitoxantrone—multiple sclerosis	8.95e-05	0.00236	CcSEcCtD
Spironolactone—Nausea—Azathioprine—multiple sclerosis	8.92e-05	0.00235	CcSEcCtD
Spironolactone—SHBG—brain—multiple sclerosis	8.88e-05	0.0202	CbGeAlD
Spironolactone—Agranulocytosis—Methotrexate—multiple sclerosis	8.85e-05	0.00234	CcSEcCtD
Spironolactone—NR3C2—brain—multiple sclerosis	8.6e-05	0.0196	CbGeAlD
Spironolactone—Discomfort—Dexamethasone—multiple sclerosis	8.57e-05	0.00226	CcSEcCtD
Spironolactone—Discomfort—Betamethasone—multiple sclerosis	8.57e-05	0.00226	CcSEcCtD
Spironolactone—AR—nervous system—multiple sclerosis	8.33e-05	0.019	CbGeAlD
Spironolactone—Anaphylactic shock—Betamethasone—multiple sclerosis	8.32e-05	0.00219	CcSEcCtD
Spironolactone—Anaphylactic shock—Dexamethasone—multiple sclerosis	8.32e-05	0.00219	CcSEcCtD
Spironolactone—Diarrhoea—Mitoxantrone—multiple sclerosis	8.31e-05	0.00219	CcSEcCtD
Spironolactone—Ill-defined disorder—Prednisone—multiple sclerosis	8.23e-05	0.00217	CcSEcCtD
Spironolactone—Feeling abnormal—Prednisolone—multiple sclerosis	8.21e-05	0.00217	CcSEcCtD
Spironolactone—Thrombocytopenia—Betamethasone—multiple sclerosis	8.14e-05	0.00215	CcSEcCtD
Spironolactone—Thrombocytopenia—Dexamethasone—multiple sclerosis	8.14e-05	0.00215	CcSEcCtD
Spironolactone—Erythema multiforme—Methotrexate—multiple sclerosis	8.05e-05	0.00212	CcSEcCtD
Spironolactone—NR3C1—medulla oblongata—multiple sclerosis	8.03e-05	0.0183	CbGeAlD
Spironolactone—AR—central nervous system—multiple sclerosis	8.02e-05	0.0183	CbGeAlD
Spironolactone—Malaise—Prednisone—multiple sclerosis	8e-05	0.00211	CcSEcCtD
Spironolactone—PGR—brain—multiple sclerosis	8e-05	0.0182	CbGeAlD
Spironolactone—Urticaria—Prednisolone—multiple sclerosis	7.92e-05	0.00209	CcSEcCtD
Spironolactone—Vomiting—Mitoxantrone—multiple sclerosis	7.72e-05	0.00204	CcSEcCtD
Spironolactone—Rash—Mitoxantrone—multiple sclerosis	7.66e-05	0.00202	CcSEcCtD
Spironolactone—Dermatitis—Mitoxantrone—multiple sclerosis	7.65e-05	0.00202	CcSEcCtD
Spironolactone—Headache—Mitoxantrone—multiple sclerosis	7.61e-05	0.00201	CcSEcCtD
Spironolactone—Feeling abnormal—Triamcinolone—multiple sclerosis	7.55e-05	0.00199	CcSEcCtD
Spironolactone—Feeling abnormal—Methylprednisolone—multiple sclerosis	7.53e-05	0.00199	CcSEcCtD
Spironolactone—Alopecia—Methotrexate—multiple sclerosis	7.53e-05	0.00199	CcSEcCtD
Spironolactone—Discomfort—Prednisone—multiple sclerosis	7.46e-05	0.00197	CcSEcCtD
Spironolactone—SLCO1A2—brain—multiple sclerosis	7.37e-05	0.0168	CbGeAlD
Spironolactone—NR3C1—midbrain—multiple sclerosis	7.34e-05	0.0167	CbGeAlD
Spironolactone—Hypersensitivity—Prednisolone—multiple sclerosis	7.34e-05	0.00194	CcSEcCtD
Spironolactone—Urticaria—Triamcinolone—multiple sclerosis	7.28e-05	0.00192	CcSEcCtD
Spironolactone—Urticaria—Methylprednisolone—multiple sclerosis	7.26e-05	0.00192	CcSEcCtD
Spironolactone—Body temperature increased—Triamcinolone—multiple sclerosis	7.24e-05	0.00191	CcSEcCtD
Spironolactone—Anaphylactic shock—Prednisone—multiple sclerosis	7.24e-05	0.00191	CcSEcCtD
Spironolactone—Nausea—Mitoxantrone—multiple sclerosis	7.21e-05	0.0019	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Betamethasone—multiple sclerosis	7.18e-05	0.00189	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	7.18e-05	0.00189	CcSEcCtD
Spironolactone—NR3C1—spinal cord—multiple sclerosis	7.16e-05	0.0163	CbGeAlD
Spironolactone—Ill-defined disorder—Methotrexate—multiple sclerosis	6.88e-05	0.00181	CcSEcCtD
Spironolactone—Feeling abnormal—Betamethasone—multiple sclerosis	6.85e-05	0.00181	CcSEcCtD
Spironolactone—Feeling abnormal—Dexamethasone—multiple sclerosis	6.85e-05	0.00181	CcSEcCtD
Spironolactone—Hypersensitivity—Triamcinolone—multiple sclerosis	6.75e-05	0.00178	CcSEcCtD
Spironolactone—Hypersensitivity—Methylprednisolone—multiple sclerosis	6.74e-05	0.00178	CcSEcCtD
Spironolactone—Malaise—Methotrexate—multiple sclerosis	6.69e-05	0.00176	CcSEcCtD
Spironolactone—Leukopenia—Methotrexate—multiple sclerosis	6.64e-05	0.00175	CcSEcCtD
Spironolactone—Urticaria—Dexamethasone—multiple sclerosis	6.61e-05	0.00174	CcSEcCtD
Spironolactone—Urticaria—Betamethasone—multiple sclerosis	6.61e-05	0.00174	CcSEcCtD
Spironolactone—Dizziness—Prednisolone—multiple sclerosis	6.59e-05	0.00174	CcSEcCtD
Spironolactone—Body temperature increased—Betamethasone—multiple sclerosis	6.57e-05	0.00173	CcSEcCtD
Spironolactone—Body temperature increased—Dexamethasone—multiple sclerosis	6.57e-05	0.00173	CcSEcCtD
Spironolactone—Pruritus—Triamcinolone—multiple sclerosis	6.48e-05	0.00171	CcSEcCtD
Spironolactone—Pruritus—Methylprednisolone—multiple sclerosis	6.47e-05	0.00171	CcSEcCtD
Spironolactone—AR—brain—multiple sclerosis	6.37e-05	0.0145	CbGeAlD
Spironolactone—Rash—Prednisolone—multiple sclerosis	6.28e-05	0.00166	CcSEcCtD
Spironolactone—Dermatitis—Prednisolone—multiple sclerosis	6.28e-05	0.00166	CcSEcCtD
Spironolactone—Diarrhoea—Methylprednisolone—multiple sclerosis	6.26e-05	0.00165	CcSEcCtD
Spironolactone—Headache—Prednisolone—multiple sclerosis	6.24e-05	0.00165	CcSEcCtD
Spironolactone—Discomfort—Methotrexate—multiple sclerosis	6.24e-05	0.00165	CcSEcCtD
Spironolactone—Confusional state—Methotrexate—multiple sclerosis	6.1e-05	0.00161	CcSEcCtD
Spironolactone—Dizziness—Triamcinolone—multiple sclerosis	6.06e-05	0.0016	CcSEcCtD
Spironolactone—Anaphylactic shock—Methotrexate—multiple sclerosis	6.05e-05	0.0016	CcSEcCtD
Spironolactone—Dizziness—Methylprednisolone—multiple sclerosis	6.05e-05	0.00159	CcSEcCtD
Spironolactone—NR3C1—nervous system—multiple sclerosis	6.04e-05	0.0137	CbGeAlD
Spironolactone—Feeling abnormal—Prednisone—multiple sclerosis	5.97e-05	0.00157	CcSEcCtD
Spironolactone—ABCB1—retina—multiple sclerosis	5.95e-05	0.0135	CbGeAlD
Spironolactone—Thrombocytopenia—Methotrexate—multiple sclerosis	5.93e-05	0.00156	CcSEcCtD
Spironolactone—Nausea—Prednisolone—multiple sclerosis	5.92e-05	0.00156	CcSEcCtD
Spironolactone—Pruritus—Dexamethasone—multiple sclerosis	5.88e-05	0.00155	CcSEcCtD
Spironolactone—Pruritus—Betamethasone—multiple sclerosis	5.88e-05	0.00155	CcSEcCtD
Spironolactone—Vomiting—Triamcinolone—multiple sclerosis	5.83e-05	0.00154	CcSEcCtD
Spironolactone—Vomiting—Methylprednisolone—multiple sclerosis	5.81e-05	0.00153	CcSEcCtD
Spironolactone—NR3C1—central nervous system—multiple sclerosis	5.81e-05	0.0132	CbGeAlD
Spironolactone—Rash—Triamcinolone—multiple sclerosis	5.78e-05	0.00152	CcSEcCtD
Spironolactone—Dermatitis—Triamcinolone—multiple sclerosis	5.77e-05	0.00152	CcSEcCtD
Spironolactone—Rash—Methylprednisolone—multiple sclerosis	5.77e-05	0.00152	CcSEcCtD
Spironolactone—Dermatitis—Methylprednisolone—multiple sclerosis	5.76e-05	0.00152	CcSEcCtD
Spironolactone—Urticaria—Prednisone—multiple sclerosis	5.75e-05	0.00152	CcSEcCtD
Spironolactone—Headache—Triamcinolone—multiple sclerosis	5.74e-05	0.00151	CcSEcCtD
Spironolactone—Headache—Methylprednisolone—multiple sclerosis	5.73e-05	0.00151	CcSEcCtD
Spironolactone—Body temperature increased—Prednisone—multiple sclerosis	5.72e-05	0.00151	CcSEcCtD
Spironolactone—Diarrhoea—Dexamethasone—multiple sclerosis	5.69e-05	0.0015	CcSEcCtD
Spironolactone—Diarrhoea—Betamethasone—multiple sclerosis	5.69e-05	0.0015	CcSEcCtD
Spironolactone—NR3C1—cerebellum—multiple sclerosis	5.68e-05	0.0129	CbGeAlD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—IL4—multiple sclerosis	5.66e-05	0.00174	CbGpPWpGaD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—IL2—multiple sclerosis	5.55e-05	0.00171	CbGpPWpGaD
Spironolactone—Dizziness—Dexamethasone—multiple sclerosis	5.5e-05	0.00145	CcSEcCtD
Spironolactone—Dizziness—Betamethasone—multiple sclerosis	5.5e-05	0.00145	CcSEcCtD
Spironolactone—Methyltestosterone—ALB—multiple sclerosis	5.48e-05	0.0291	CrCbGaD
Spironolactone—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	5.46e-05	0.00168	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—PTBP1—multiple sclerosis	5.46e-05	0.00168	CbGpPWpGaD
Spironolactone—Nausea—Triamcinolone—multiple sclerosis	5.44e-05	0.00144	CcSEcCtD
Spironolactone—Nausea—Methylprednisolone—multiple sclerosis	5.43e-05	0.00143	CcSEcCtD
Spironolactone—Somnolence—Methotrexate—multiple sclerosis	5.38e-05	0.00142	CcSEcCtD
Spironolactone—NR3C2—Gene Expression—ZFP36L1—multiple sclerosis	5.37e-05	0.00165	CbGpPWpGaD
Spironolactone—Hypersensitivity—Prednisone—multiple sclerosis	5.34e-05	0.00141	CcSEcCtD
Spironolactone—Vomiting—Betamethasone—multiple sclerosis	5.29e-05	0.00139	CcSEcCtD
Spironolactone—Vomiting—Dexamethasone—multiple sclerosis	5.29e-05	0.00139	CcSEcCtD
Spironolactone—CYP11B2—Biological oxidations—POMC—multiple sclerosis	5.28e-05	0.00163	CbGpPWpGaD
Spironolactone—AR—Notch-mediated HES/HEY network—STAT3—multiple sclerosis	5.26e-05	0.00162	CbGpPWpGaD
Spironolactone—Rash—Betamethasone—multiple sclerosis	5.24e-05	0.00138	CcSEcCtD
Spironolactone—Rash—Dexamethasone—multiple sclerosis	5.24e-05	0.00138	CcSEcCtD
Spironolactone—Dermatitis—Dexamethasone—multiple sclerosis	5.24e-05	0.00138	CcSEcCtD
Spironolactone—Dermatitis—Betamethasone—multiple sclerosis	5.24e-05	0.00138	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Methotrexate—multiple sclerosis	5.22e-05	0.00138	CcSEcCtD
Spironolactone—Headache—Betamethasone—multiple sclerosis	5.21e-05	0.00137	CcSEcCtD
Spironolactone—Headache—Dexamethasone—multiple sclerosis	5.21e-05	0.00137	CcSEcCtD
Spironolactone—SLCO1A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	5.19e-05	0.0016	CbGpPWpGaD
Spironolactone—CYP2C8—brain—multiple sclerosis	5.15e-05	0.0117	CbGeAlD
Spironolactone—Pruritus—Prednisone—multiple sclerosis	5.12e-05	0.00135	CcSEcCtD
Spironolactone—NR3C1—Transcription factor regulation in adipogenesis—IL6—multiple sclerosis	5.12e-05	0.00158	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	5.09e-05	0.00157	CbGpPWpGaD
Spironolactone—PGR—Validated nuclear estrogen receptor alpha network—MYC—multiple sclerosis	5.01e-05	0.00154	CbGpPWpGaD
Spironolactone—Feeling abnormal—Methotrexate—multiple sclerosis	4.99e-05	0.00132	CcSEcCtD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.98e-05	0.00153	CbGpPWpGaD
Spironolactone—Diarrhoea—Prednisone—multiple sclerosis	4.95e-05	0.00131	CcSEcCtD
Spironolactone—Nausea—Betamethasone—multiple sclerosis	4.94e-05	0.0013	CcSEcCtD
Spironolactone—Nausea—Dexamethasone—multiple sclerosis	4.94e-05	0.0013	CcSEcCtD
Spironolactone—CYP11B1—Metabolism—SRM—multiple sclerosis	4.91e-05	0.00151	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.87e-05	0.0015	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.87e-05	0.0015	CbGpPWpGaD
Spironolactone—Urticaria—Methotrexate—multiple sclerosis	4.81e-05	0.00127	CcSEcCtD
Spironolactone—AR—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	4.8e-05	0.00148	CbGpPWpGaD
Spironolactone—Dizziness—Prednisone—multiple sclerosis	4.79e-05	0.00126	CcSEcCtD
Spironolactone—Body temperature increased—Methotrexate—multiple sclerosis	4.78e-05	0.00126	CcSEcCtD
Spironolactone—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	4.74e-05	0.00146	CbGpPWpGaD
Spironolactone—NR3C1—brain—multiple sclerosis	4.61e-05	0.0105	CbGeAlD
Spironolactone—Vomiting—Prednisone—multiple sclerosis	4.6e-05	0.00121	CcSEcCtD
Spironolactone—ABCB1—Allograft Rejection—CD28—multiple sclerosis	4.6e-05	0.00142	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—IL10—multiple sclerosis	4.58e-05	0.00141	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—CD80—multiple sclerosis	4.57e-05	0.00141	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—CCL2—multiple sclerosis	4.57e-05	0.00141	CbGpPWpGaD
Spironolactone—Rash—Prednisone—multiple sclerosis	4.57e-05	0.0012	CcSEcCtD
Spironolactone—Dermatitis—Prednisone—multiple sclerosis	4.56e-05	0.0012	CcSEcCtD
Spironolactone—CYP11B1—Biological oxidations—POMC—multiple sclerosis	4.55e-05	0.0014	CbGpPWpGaD
Spironolactone—AR—Gene Expression—ZNF746—multiple sclerosis	4.55e-05	0.0014	CbGpPWpGaD
Spironolactone—Headache—Prednisone—multiple sclerosis	4.54e-05	0.0012	CcSEcCtD
Spironolactone—ABCC2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.54e-05	0.0014	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—multiple sclerosis	4.5e-05	0.00138	CbGpPWpGaD
Spironolactone—Hypersensitivity—Methotrexate—multiple sclerosis	4.46e-05	0.00118	CcSEcCtD
Spironolactone—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	4.4e-05	0.00136	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	4.37e-05	0.00135	CbGpPWpGaD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—TGFB1—multiple sclerosis	4.33e-05	0.00133	CbGpPWpGaD
Spironolactone—Nausea—Prednisone—multiple sclerosis	4.3e-05	0.00113	CcSEcCtD
Spironolactone—ABCB1—medulla oblongata—multiple sclerosis	4.3e-05	0.00979	CbGeAlD
Spironolactone—NR3C2—Generic Transcription Pathway—VDR—multiple sclerosis	4.29e-05	0.00132	CbGpPWpGaD
Spironolactone—Pruritus—Methotrexate—multiple sclerosis	4.28e-05	0.00113	CcSEcCtD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—MAPK1—multiple sclerosis	4.24e-05	0.00131	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—CD40—multiple sclerosis	4.2e-05	0.00129	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—PABPC1—multiple sclerosis	4.16e-05	0.00128	CbGpPWpGaD
Spironolactone—AR—Gene Expression—PTBP1—multiple sclerosis	4.16e-05	0.00128	CbGpPWpGaD
Spironolactone—Diarrhoea—Methotrexate—multiple sclerosis	4.14e-05	0.00109	CcSEcCtD
Spironolactone—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	4.14e-05	0.00128	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—U2AF2—multiple sclerosis	4.14e-05	0.00127	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—HNRNPA1—multiple sclerosis	4.14e-05	0.00127	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—POMC—multiple sclerosis	4.11e-05	0.00127	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	4.08e-05	0.00126	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CYP27B1—multiple sclerosis	4.01e-05	0.00124	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CYP24A1—multiple sclerosis	4.01e-05	0.00124	CbGpPWpGaD
Spironolactone—Dizziness—Methotrexate—multiple sclerosis	4e-05	0.00106	CcSEcCtD
Spironolactone—ABCB1—midbrain—multiple sclerosis	3.93e-05	0.00895	CbGeAlD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.92e-05	0.00121	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—IFNG—multiple sclerosis	3.88e-05	0.0012	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—multiple sclerosis	3.87e-05	0.00119	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—TYK2—multiple sclerosis	3.86e-05	0.00119	CbGpPWpGaD
Spironolactone—Vomiting—Methotrexate—multiple sclerosis	3.85e-05	0.00102	CcSEcCtD
Spironolactone—ABCB1—spinal cord—multiple sclerosis	3.83e-05	0.00873	CbGeAlD
Spironolactone—Rash—Methotrexate—multiple sclerosis	3.82e-05	0.00101	CcSEcCtD
Spironolactone—Dermatitis—Methotrexate—multiple sclerosis	3.81e-05	0.00101	CcSEcCtD
Spironolactone—Headache—Methotrexate—multiple sclerosis	3.79e-05	0.001	CcSEcCtD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	3.78e-05	0.00117	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.77e-05	0.00116	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—RPL5—multiple sclerosis	3.75e-05	0.00116	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—GPC5—multiple sclerosis	3.67e-05	0.00113	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	3.65e-05	0.00112	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	3.64e-05	0.00112	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—FAS—multiple sclerosis	3.61e-05	0.00111	CbGpPWpGaD
Spironolactone—Nausea—Methotrexate—multiple sclerosis	3.59e-05	0.000948	CcSEcCtD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	3.49e-05	0.00108	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	3.48e-05	0.00107	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CYP27B1—multiple sclerosis	3.46e-05	0.00107	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CYP24A1—multiple sclerosis	3.46e-05	0.00107	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—IL2—multiple sclerosis	3.45e-05	0.00106	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—ZNF746—multiple sclerosis	3.45e-05	0.00106	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.44e-05	0.00106	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—multiple sclerosis	3.42e-05	0.00105	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	3.41e-05	0.00105	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.38e-05	0.00104	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—CD86—multiple sclerosis	3.28e-05	0.00101	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—ZFP36L1—multiple sclerosis	3.27e-05	0.00101	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—MMP9—multiple sclerosis	3.27e-05	0.00101	CbGpPWpGaD
Spironolactone—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.26e-05	0.001	CbGpPWpGaD
Spironolactone—ABCB1—nervous system—multiple sclerosis	3.23e-05	0.00736	CbGeAlD
Spironolactone—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	3.22e-05	0.000992	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—IL10—multiple sclerosis	3.22e-05	0.000992	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—multiple sclerosis	3.2e-05	0.000984	CbGpPWpGaD
Spironolactone—Testosterone—ALB—multiple sclerosis	3.18e-05	0.0169	CrCbGaD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	3.16e-05	0.000974	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GPC5—multiple sclerosis	3.16e-05	0.000974	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—STAT3—multiple sclerosis	3.16e-05	0.000973	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PTBP1—multiple sclerosis	3.15e-05	0.000972	CbGpPWpGaD
Spironolactone—AR—Gene Expression—U2AF2—multiple sclerosis	3.15e-05	0.000971	CbGpPWpGaD
Spironolactone—AR—Gene Expression—HNRNPA1—multiple sclerosis	3.15e-05	0.000971	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—IL4—multiple sclerosis	3.13e-05	0.000965	CbGpPWpGaD
Spironolactone—ABCB1—central nervous system—multiple sclerosis	3.11e-05	0.00708	CbGeAlD
Spironolactone—PGR—Signaling Pathways—LINGO1—multiple sclerosis	3.1e-05	0.000955	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—SRM—multiple sclerosis	3.08e-05	0.000948	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	3.06e-05	0.000943	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—RRM1—multiple sclerosis	3.04e-05	0.000937	CbGpPWpGaD
Spironolactone—ABCB1—cerebellum—multiple sclerosis	3.04e-05	0.00692	CbGeAlD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—IL2—multiple sclerosis	3.04e-05	0.000936	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.98e-05	0.000919	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—PGR—multiple sclerosis	2.96e-05	0.00091	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—FAS—multiple sclerosis	2.89e-05	0.000889	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	2.87e-05	0.000884	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—PGR—multiple sclerosis	2.85e-05	0.000878	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	2.84e-05	0.000874	CbGpPWpGaD
Spironolactone—NR3C1—Endoderm Differentiation—TGFB1—multiple sclerosis	2.75e-05	0.000848	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.72e-05	0.000837	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—MYC—multiple sclerosis	2.7e-05	0.000831	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—TGFB1—multiple sclerosis	2.69e-05	0.000829	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TAGAP—multiple sclerosis	2.69e-05	0.000828	CbGpPWpGaD
Spironolactone—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.64e-05	0.000813	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.64e-05	0.000812	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—RRM1—multiple sclerosis	2.62e-05	0.000807	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—VDR—multiple sclerosis	2.61e-05	0.000805	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	2.59e-05	0.000799	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—PABPC1—multiple sclerosis	2.54e-05	0.000781	CbGpPWpGaD
Spironolactone—AR—Gene Expression—ZFP36L1—multiple sclerosis	2.49e-05	0.000767	CbGpPWpGaD
Spironolactone—ABCB1—brain—multiple sclerosis	2.47e-05	0.00562	CbGeAlD
Spironolactone—PGR—Signaling by ERBB4—MAPK1—multiple sclerosis	2.46e-05	0.000756	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	2.4e-05	0.000741	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.4e-05	0.00074	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	2.4e-05	0.000739	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—CD80—multiple sclerosis	2.4e-05	0.000738	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.39e-05	0.000737	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.39e-05	0.000737	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—U2AF2—multiple sclerosis	2.39e-05	0.000736	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—HNRNPA1—multiple sclerosis	2.39e-05	0.000736	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.36e-05	0.000727	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—S1PR1—multiple sclerosis	2.35e-05	0.000724	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—multiple sclerosis	2.33e-05	0.000716	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—RPL5—multiple sclerosis	2.29e-05	0.000704	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GPC5—multiple sclerosis	2.29e-05	0.000704	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CYP24A1—multiple sclerosis	2.17e-05	0.000668	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CYP27B1—multiple sclerosis	2.17e-05	0.000668	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—PGR—multiple sclerosis	2.16e-05	0.000666	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.13e-05	0.000657	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.12e-05	0.000653	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	2.07e-05	0.000639	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—VDR—multiple sclerosis	2.07e-05	0.000636	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.03e-05	0.000626	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—IL6—multiple sclerosis	2.03e-05	0.000625	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.03e-05	0.000624	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—RGS1—multiple sclerosis	2e-05	0.000616	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—VDR—multiple sclerosis	1.99e-05	0.000613	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GPC5—multiple sclerosis	1.98e-05	0.000611	CbGpPWpGaD
Spironolactone—AR—Gene Expression—PABPC1—multiple sclerosis	1.93e-05	0.000595	CbGpPWpGaD
Spironolactone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	1.93e-05	0.000594	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	1.92e-05	0.000592	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GPR65—multiple sclerosis	1.89e-05	0.000584	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	1.89e-05	0.000583	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—ZFP36L1—multiple sclerosis	1.89e-05	0.000582	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—IL6—multiple sclerosis	1.89e-05	0.000581	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	1.88e-05	0.000579	CbGpPWpGaD
Spironolactone—SLCO1A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.87e-05	0.000576	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.85e-05	0.000569	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	1.82e-05	0.000562	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—IL6—multiple sclerosis	1.79e-05	0.00055	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—STAT3—multiple sclerosis	1.77e-05	0.000545	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.75e-05	0.000538	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—BCHE—multiple sclerosis	1.75e-05	0.000538	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—TNF—multiple sclerosis	1.74e-05	0.000537	CbGpPWpGaD
Spironolactone—AR—Gene Expression—RPL5—multiple sclerosis	1.74e-05	0.000537	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCR1—multiple sclerosis	1.73e-05	0.000534	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CXCL13—multiple sclerosis	1.73e-05	0.000534	CbGpPWpGaD
Spironolactone—ABCC2—NRF2 pathway—TGFB1—multiple sclerosis	1.71e-05	0.000526	CbGpPWpGaD
Spironolactone—NR3C2—Generic Transcription Pathway—MYC—multiple sclerosis	1.71e-05	0.000525	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	1.69e-05	0.00052	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—IL2—multiple sclerosis	1.68e-05	0.000518	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	1.66e-05	0.000513	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—RRM1—multiple sclerosis	1.64e-05	0.000506	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—TGFB1—multiple sclerosis	1.64e-05	0.000505	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.62e-05	0.000498	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.59e-05	0.000491	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.59e-05	0.000491	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.59e-05	0.000489	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.56e-05	0.00048	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—TNF—multiple sclerosis	1.53e-05	0.000472	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SRM—multiple sclerosis	1.51e-05	0.000466	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—VDR—multiple sclerosis	1.51e-05	0.000465	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—BCHE—multiple sclerosis	1.51e-05	0.000464	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.48e-05	0.000457	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PABPC1—multiple sclerosis	1.47e-05	0.000451	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	1.42e-05	0.000439	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—IL6—multiple sclerosis	1.41e-05	0.000434	CbGpPWpGaD
Spironolactone—CYP2C8—Biological oxidations—POMC—multiple sclerosis	1.4e-05	0.000432	CbGpPWpGaD
Spironolactone—AR—Gene Expression—PGR—multiple sclerosis	1.37e-05	0.000422	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	1.32e-05	0.000408	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—RPL5—multiple sclerosis	1.32e-05	0.000407	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SRM—multiple sclerosis	1.32e-05	0.000406	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	1.31e-05	0.000404	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.28e-05	0.000393	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.28e-05	0.000393	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—VDR—multiple sclerosis	1.26e-05	0.000387	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—IL6—multiple sclerosis	1.24e-05	0.000381	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCL3—multiple sclerosis	1.23e-05	0.00038	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—TNF—multiple sclerosis	1.23e-05	0.000377	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PTGER4—multiple sclerosis	1.19e-05	0.000366	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CXCR3—multiple sclerosis	1.15e-05	0.000354	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CD28—multiple sclerosis	1.14e-05	0.00035	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.13e-05	0.000348	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCR2—multiple sclerosis	1.12e-05	0.000344	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.1e-05	0.000337	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	1.07e-05	0.000329	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	1.07e-05	0.000328	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	1.07e-05	0.000328	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—APOE—multiple sclerosis	1.05e-05	0.000324	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.04e-05	0.000321	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PGR—multiple sclerosis	1.04e-05	0.000321	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—MYC—multiple sclerosis	1.04e-05	0.00032	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CNR1—multiple sclerosis	1.03e-05	0.000317	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.99e-06	0.000308	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GPC5—multiple sclerosis	9.75e-06	0.0003	CbGpPWpGaD
Spironolactone—AR—Gene Expression—VDR—multiple sclerosis	9.59e-06	0.000295	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.5e-06	0.000293	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—BCHE—multiple sclerosis	9.44e-06	0.000291	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP27B1—multiple sclerosis	9.28e-06	0.000286	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP24A1—multiple sclerosis	9.28e-06	0.000286	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CXCL10—multiple sclerosis	9.28e-06	0.000286	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—APOE—multiple sclerosis	9.06e-06	0.000279	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—POMC—multiple sclerosis	9.03e-06	0.000278	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.65e-06	0.000266	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GPC5—multiple sclerosis	8.49e-06	0.000262	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—ALB—multiple sclerosis	8.23e-06	0.000254	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—MYC—multiple sclerosis	8.21e-06	0.000253	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CD86—multiple sclerosis	8.11e-06	0.00025	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—RRM1—multiple sclerosis	8.08e-06	0.000249	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCL5—multiple sclerosis	7.99e-06	0.000246	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—MYC—multiple sclerosis	7.91e-06	0.000244	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—POMC—multiple sclerosis	7.78e-06	0.00024	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SPP1—multiple sclerosis	7.4e-06	0.000228	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—VDR—multiple sclerosis	7.27e-06	0.000224	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCR5—multiple sclerosis	7.2e-06	0.000222	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ALB—multiple sclerosis	7.09e-06	0.000218	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL2RA—multiple sclerosis	7.09e-06	0.000218	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—RRM1—multiple sclerosis	7.04e-06	0.000217	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—APOE—multiple sclerosis	6.55e-06	0.000202	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	6.49e-06	0.0002	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	6.48e-06	0.000199	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	6.35e-06	0.000196	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.27e-06	0.000193	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	6.05e-06	0.000186	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—MYC—multiple sclerosis	6e-06	0.000185	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CD80—multiple sclerosis	5.92e-06	0.000182	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—APOE—multiple sclerosis	5.68e-06	0.000175	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—POMC—multiple sclerosis	5.62e-06	0.000173	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCL2—multiple sclerosis	5.5e-06	0.000169	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.38e-06	0.000166	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—MYC—multiple sclerosis	5e-06	0.000154	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TYK2—multiple sclerosis	5e-06	0.000154	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.91e-06	0.000151	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—POMC—multiple sclerosis	4.88e-06	0.00015	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—BCHE—multiple sclerosis	4.64e-06	0.000143	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ALB—multiple sclerosis	4.45e-06	0.000137	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL2—multiple sclerosis	4.16e-06	0.000128	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.07e-06	0.000125	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—BCHE—multiple sclerosis	4.04e-06	0.000124	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MMP9—multiple sclerosis	3.94e-06	0.000121	CbGpPWpGaD
Spironolactone—AR—Gene Expression—MYC—multiple sclerosis	3.81e-06	0.000117	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—STAT3—multiple sclerosis	3.5e-06	0.000108	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MYC—multiple sclerosis	3.25e-06	0.0001	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TGFB1—multiple sclerosis	3.24e-06	9.99e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MAPK1—multiple sclerosis	3.18e-06	9.8e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—MYC—multiple sclerosis	2.89e-06	8.9e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—APOE—multiple sclerosis	2.79e-06	8.6e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL6—multiple sclerosis	2.44e-06	7.53e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—APOE—multiple sclerosis	2.43e-06	7.49e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—POMC—multiple sclerosis	2.4e-06	7.38e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ALB—multiple sclerosis	2.19e-06	6.73e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—POMC—multiple sclerosis	2.09e-06	6.43e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ALB—multiple sclerosis	1.9e-06	5.86e-05	CbGpPWpGaD
